Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
THURSDAY, May 8, 2025-- Ultra-hypofractionated (UHF) radiotherapy delivered over two weeks is noninferior to conventionally fractionated (CF) radiotherapy delivered over eight weeks for localized prostate cancer up to 10 years, according to a...